Invacare Past Earnings Performance
Past criteria checks 0/6
Invacare's earnings have been declining at an average annual rate of -2.6%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 4.5% per year.
Key information
-2.6%
Earnings growth rate
-0.2%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -4.5% |
| Return on equity | -124.6% |
| Net Margin | -13.6% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
Invacare falls on bankruptcy filing
Feb 01Invacare announces additional draw of $5.5M term loans
Dec 27Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates
Nov 14
Invacare GAAP EPS of -$0.92, revenue of $170.4M
Nov 07Invacare receives non-compliance letter from NYSE
Sep 29Invacare names Geoffrey Purtill as interim president and executive chief
Aug 29Invacare adds two new directors after deal with largest investor Azurite
Aug 23Returns Are Gaining Momentum At Invacare (NYSE:IVC)
Apr 30Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky
Jan 27Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)
Dec 01Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load
Sep 30When Should You Buy Invacare Corporation (NYSE:IVC)?
Aug 06Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)
May 14Invacare EPS misses by $0.02, misses on revenue
May 05Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)
May 03Invacare Corporation's (NYSE:IVC) Path To Profitability
Mar 03Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet
Feb 05
What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?
Jan 10Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.
Dec 14Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit
Nov 23Invacare Corporation 2020 Q3 - Results - Earnings Call Presentation
Oct 30Revenue & Expenses Breakdown
How Invacare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 742 | -101 | 228 | 0 |
| 30 Sep 22 | 787 | -79 | 225 | 0 |
| 30 Jun 22 | 840 | -67 | 223 | 0 |
| 31 Mar 22 | 877 | -56 | 232 | 0 |
| 31 Dec 21 | 872 | -46 | 231 | 0 |
| 30 Sep 21 | 870 | -53 | 241 | 0 |
| 30 Jun 21 | 858 | -37 | 240 | 0 |
| 31 Mar 21 | 828 | -43 | 234 | 0 |
| 31 Dec 20 | 851 | -28 | 237 | 0 |
| 30 Sep 20 | 860 | -42 | 236 | 0 |
| 30 Jun 20 | 883 | -43 | 246 | 0 |
| 31 Mar 20 | 923 | -39 | 256 | 0 |
| 31 Dec 19 | 928 | -53 | 260 | 0 |
| 30 Sep 19 | 940 | -36 | 264 | 0 |
| 30 Jun 19 | 948 | -40 | 270 | 0 |
| 31 Mar 19 | 959 | -44 | 276 | 0 |
| 31 Dec 18 | 972 | -44 | 282 | 0 |
| 30 Sep 18 | 978 | -60 | 288 | 0 |
| 30 Jun 18 | 984 | -67 | 294 | 0 |
| 31 Mar 18 | 972 | -74 | 295 | 0 |
| 31 Dec 17 | 966 | -77 | 297 | 0 |
| 30 Sep 17 | 963 | -77 | 299 | 0 |
| 30 Jun 17 | 980 | -63 | 301 | 0 |
| 31 Mar 17 | 1,022 | -51 | 304 | 0 |
| 31 Dec 16 | 1,047 | -43 | 304 | 0 |
| 30 Sep 16 | 1,084 | -28 | 303 | 0 |
| 30 Jun 16 | 1,100 | -31 | 303 | 0 |
Quality Earnings: IVCR.Q is currently unprofitable.
Growing Profit Margin: IVCR.Q is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IVCR.Q is unprofitable, and losses have increased over the past 5 years at a rate of 2.6% per year.
Accelerating Growth: Unable to compare IVCR.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IVCR.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).
Return on Equity
High ROE: IVCR.Q has a negative Return on Equity (-124.64%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/05/05 06:11 |
| End of Day Share Price | 2023/05/05 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Invacare Corporation is covered by 9 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Labick | CJS Securities, Inc. |
| Constantine Davides | D. Boral Capital LLC. |
| Matthew Mishan | KeyBanc Capital Markets Inc. |